Stephan Beck FMedSci[1] is a German-British geneticist and Professor of Medical Genomics at the University College London Cancer Institute.[2]
Stephan Beck | |
|---|---|
| Alma mater | University of Konstanz |
| Known for | |
| Scientific career | |
| Institutions | University College London University of Cambridge |
Research
editStephan Beck received his PhD in 1985 from the University of Konstanz, where he studied DNA structure.[3] He held positions at the MRC Laboratory of Molecular Biology in Cambridge, Millipore Corporation in Boston, and the Imperial Cancer Research Fund in London, before joining the Wellcome Trust Sanger Institute in 1996.[4] As Head of Human Sequencing (1998–2006), Beck participated in sequencing and analyzing the human and mouse genomes and established the first DNA methylation maps of human chromosomes 6, 20, and 22.[5]
He is the director of the Personal Genome Project UK, and serves on the advisory board of the Human Epigenome Project.[6][7] Beck is a Fellow of the Academy of Medical Sciences and a recipient of a Royal Society Wolfson Research Merit Award.[8][9]
Beck is the principal investigator of the medical genomics team at the University College London Cancer Institute.[10][11]
References
edit- ^ "Stephan Beck Profile". acmedsci.ac.uk.
- ^ "Stephan Beck Genome Medicine Interview". BMC.
- ^ "PhD thesis article". embo.org.
- ^ "Stephan Beck Profile". UCL.
- ^ "DNA methylome paper". Nature Genetics.
- ^ "IHEC Bioethics Chairs". IHEC.
- ^ "Personal Genome Project UK". PGP.
- ^ "Wolfson Awards UCL". UCL.
- ^ "List of Fellows of the Academy of Medical Sciences". acmedsci.ac.uk.
- ^ "Stephan Beck Lab Profile". UCL.
- ^ "Beck, Stephan". Google scholar.